CAS: 1206163-45-2
GLPG-0778
CAS:1206163-45-2
Formula:
C22H23N5O2
Purity:
%
Color and Shape:
Solid
Molecular weight:
389.45031999999986
Ref: IN-DA008TN5
| 5mg | 56.00 € | ||
| 10mg | 92.00 € |
Estimated delivery in United States, on Thursday 27 Mar 2025
Solcitinib
CAS:1206163-45-2
Solcitinib (GLPG-0778), a JAK1 inhibitor, may treat psoriasis, ulcerative colitis, and lupus.
Formula:
C22H23N5O2
Purity:
99.61% - 99.82%
Color and Shape:
Solid
Molecular weight:
389.45
Ref: TM-T3620
| 5mg | 50.00 € | ||
| 10mg | 64.00 € | ||
| 25mg | 90.00 € | ||
| 50mg | 117.00 € | ||
| 100mg | 187.00 € | ||
| 200mg | 301.00 € | ||
| 1mL*10mM (DMSO) | 51.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
![N-(5-(4-(3,3-Dimethylazetidine-1-carbonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanec…](https://static.cymitquimica.com/products/10/thumb/F497231.jpg)
N-(5-(4-(3,3-Dimethylazetidine-1-carbonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
CAS:1206163-45-2
Purity:
95.0%
Molecular weight:
389.4590148925781
Ref: 10-F497231
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 8 Apr 2025
Solcitinib
CAS:1206163-45-2
Solcitinib is a Jak1 inhibitor that is being evaluated for its potential to treat cancer. …
Formula:
C22H23N5O2
Purity:
Min. 95%
Molecular weight:
389.45 g/mol
Ref: 3D-GYB16345
| 50mg | 1,065.00 € | ||
| 100mg | 1,482.00 € |
Estimated delivery in United States, on Thursday 8 May 2025
